Market Cap
$82.44 B
-$646.15 M-0.78%
Fri, 29 Nov 2024 21:06:33 GMT
Summary:
Regeneron Pharmaceuticals market capitalization is currently $82.44 billion, with a fall of -$646.15 million (-0.78%) during the most recent trading day. Over the past year, it has dropped by -$5.65 billion (-6.42%). REGN market cap is now -37.64% below its all-time high of $132.20 billion.REGN Market Cap Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
REGN Market Cap Performance
| PeriodPeriod | Market capMarket cap | PricePrice | Shares outstandingShares outstanding | TTM Dividend per shareTTM Dividend per share |
|---|---|---|---|---|
| todaytoday | -0.8% | -0.8% | -0.2% | - |
| 1 m1 month | -19.2% | -19.2% | - | - |
| 3 m3 months | -36.5% | -36.3% | - | - |
| 6 m6 months | -22.6% | -22.4% | - | - |
| ytdytd | -13.9% | -14.3% | - | - |
| 1 y1 year | -6.4% | -7.2% | +1.0% | - |
| 5 y5 years | +103.5% | +103.3% | +0.1% | - |
REGN Market Cap High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | $105 B | -21.8% | $81 B | +1.4% |
| 3 m | 3 months | $130 B | -36.5% | $81 B | +1.4% |
| 6 m | 6 months | $132 B | -37.6% | $81 B | +1.4% |
| 1 y | 1 year | $132 B | -37.6% | $81 B | +1.4% |
| 3 y | 3 years | $132 B | -37.6% | $60 B | +36.9% |
| 5 y | 5 years | $132 B | -37.6% | $37 B | +122.4% |
| alltime | all time | $132 B | -37.6% | $57 M | >+9999.0% |
Regeneron Pharmaceuticals Market Cap History
| Date | Value |
|---|---|
| 2024 | $82.44 B(-13.9%) |
| 2023 | $95.76 B(+21.0%) |
| 2022 | $79.13 B(+15.3%) |
| 2021 | $68.63 B(+32.8%) |
| 2020 | $51.67 B(+24.8%) |
| 2019 | $41.41 B(+1.7%) |
| 2018 | $40.71 B(+0.6%) |
| 2017 | $40.46 B(+4.0%) |
| 2016 | $38.91 B(-31.5%) |
| 2015 | $56.81 B(+35.2%) |
| 2014 | $42.02 B(+53.2%) |
| 2013 | $27.44 B(+64.9%) |
| 2012 | $16.64 B(+223.6%) |
| 2011 | $5.14 B(+75.2%) |
| 2010 | $2.94 B(+49.7%) |
| 2009 | $1.96 B(+34.1%) |
| 2008 | $1.46 B(-23.2%) |
| Date | Value |
|---|---|
| 2007 | $1.90 B(+45.1%) |
| 2006 | $1.31 B(+46.3%) |
| 2005 | $897.38 M(+74.4%) |
| 2004 | $514.47 M(-37.1%) |
| 2003 | $817.33 M(-0.8%) |
| 2002 | $823.76 M(-33.5%) |
| 2001 | $1.24 B(-4.6%) |
| 2000 | $1.30 B(+224.0%) |
| 1999 | $400.64 M(+75.1%) |
| 1998 | $228.76 M(-13.6%) |
| 1997 | $264.77 M(-36.0%) |
| 1996 | $414.03 M(+48.7%) |
| 1995 | $278.40 M(+392.0%) |
| 1994 | $56.59 M(-80.6%) |
| 1993 | $292.24 M(+58.6%) |
| 1992 | $184.24 M(-33.8%) |
| 1991 | $278.45 M |
FAQ
- What is Regeneron Pharmaceuticals market capitalization?
- What is the all time high market cap for Regeneron Pharmaceuticals?
- What is REGN market capitalization year-to-date change?
- What is Regeneron Pharmaceuticals market cap year-on-year change?
What is Regeneron Pharmaceuticals market capitalization?
The current market cap of REGN is $82.44 B
What is the all time high market cap for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high market capitalization is $132.20 B
What is REGN market capitalization year-to-date change?
Regeneron Pharmaceuticals market capitalization has changed by -$13.31 B (-13.90%) since the beginning of the year
What is Regeneron Pharmaceuticals market cap year-on-year change?
Over the past year, REGN market capitalization has changed by -$5.65 B (-6.42%)